Trials / Completed
CompletedNCT02385318
To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 519 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare safety and efficacy of Perrigo's drug product compared to an FDA approved drug product in the treatment of actinic keratosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ingenol Mebutate (Perrigo) | |
| DRUG | Ingenol Mebutate (Reference) | |
| DRUG | Placebo gel |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-03-11
- Last updated
- 2021-11-02
- Results posted
- 2021-01-22
Source: ClinicalTrials.gov record NCT02385318. Inclusion in this directory is not an endorsement.